Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03403400 · ClinicalTrials.gov registry record · NA

"Can A Prescribed Walking Program With or Without Monitoring Impact Dizziness in the Older Adults?"

A NA study of Dizziness, sponsored by AdventHealth.

Completed
Registry status
NA
Development phase
17
Enrollment target
2
Study locations

NCT03403400: Completed NA study of Dizziness, sponsored by AdventHealth.

NCT03403400 is a NA study of Dizziness that has completed, run by AdventHealth. The registered enrollment target is 17 participants, below the 10,102-participant average among 8 other Dizziness trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03403400, a NA study of Dizziness, has completed, sponsored by AdventHealth.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
2
Study locations

Study Summary

Dizziness is a common complaint reported by 30% of people above 65 years of age and by more than 50% of those 90 years of age and older.(1) Age-related decline in vestibular, musculoskeletal, and neurologic performances compounded by a vestibular pathology can result to debilitating physical and psychological consequences. Dizziness is associated with falls,(2) disability (3) and physical inactivity.(4) Walking for endurance is cited as one of the components of vestibular rehabilitation (VR) in the "Clinical Practice Guideline for Peripheral Vestibular Hypofunction".(5) Although walking can offset the avoidance of physical activity from symptom provocation, no direct evidence has been found to support the effect of walking on postural and dynamic stability, function, and participation in people with dizziness. The primary purpose of this study is to evaluate the impact of walking as an exercise component of VR on both primary and secondary vestibular-specific outcome measures. The primary outcomes are mCTSIB, TUG test, DGI, and DHI, while the secondary outcomes are the total number of visits and length of interventions (in weeks). The second purpose is to evaluate whether pedometers increase the adherence of older adults with vestibular issues to a walking program. This will be measured by change in physical activity, as represented by International Physical Activity Questionnaire (IPAQ) Walking Metabolic Equivalent of Task (MET)-minutes/week and IPAQ Total Physical Activity MET-minutes/week scores from the IPAQ short form during the episode of care (admission and discharge) and on four-weeks follow-up compared to those patients who only received instructions to walk without a pedometer. The third purpose of this study is to establish test-retest reliability of the TUG test on older adults with dizziness. Lastly, the fourth purpose of this study to investigate if the TUG, DGI, and mCTSIB are significant and strong predictors of the DHI in older adults with dizzines

Primary Outcome

The mCTSIB quantifies the ability of the patient to use information from somatosensory, visual and vestibular system effectively for postural stability. This test eliminated conditions 3 and 6 of the original CTSIB, which use an altered visual input (visual conflict dome). It is performed with the feet together, a modification from the original test, which is with feet apart.(7) The four conditions of mCTSIB are standing on firm surface eyes open, standing on firm surface eyes closed, standing o

Conditions Studied

Interventions

  • BEHAVIORAL VRWP Group
  • BEHAVIORAL VRW Group

Study Locations (2)

Florida

  • Florida Hospital East Orlando - Orlando
  • Florida Hospital Winter Park - Winter Park

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2018-07-18
Est. Completion 2019-09-05
Phase NA
AdventHealth

95 total trials

What the finished NCT03403400 record still lists

NCT03403400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 10,102-participant average among 8 other Dizziness trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Dizziness appearing as the primary indexed condition, and to 2 interventions - of which VRWP Group is the first listed.

NCT03403400 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03403400 about?

NCT03403400 is a clinical study titled ""Can A Prescribed Walking Program With or Without Monitoring Impact Dizziness in the Older Adults?"". Dizziness is a common complaint reported by 30% of people above 65 years of age and by more than 50% of those 90 years of age and older.(1) Age-related decline in vestibular, musculoskeletal, and neurologic performances compounded by a vestibular pathology can result to debilitating physical and psy...

What is the current status of trial NCT03403400?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2018-07-18. Estimated completion is 2019-09-05.

What conditions does trial NCT03403400 study?

This clinical trial studies the following conditions: Dizziness.

What interventions are being tested in trial NCT03403400?

The interventions under investigation include: VRWP Group (BEHAVIORAL), VRW Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03403400?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03403400 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dizziness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03403400's enrollment target sits among peer trials

17 9th of 8 the lowest of 8 other Dizziness trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dizziness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03403400, the US trial registry maintained by the National Library of Medicine. NCT03403400 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.